GLP-1 and GIP receptor agonists in the treatment of Parkinson’s disease: Translational systematic review and meta-analysis protocol of clinical and preclinical studies
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
GLP-1 and GIP receptor agonists in the treatment of Parkinson’s disease: Translational systematic review and meta-analysis protocol of clinical and preclinical studies
Authors
Keywords
Parkinson disease, Drug therapy, Dopaminergics, Medical risk factors, Metaanalysis, Systematic reviews, Dopamine, Randomized controlled trials
Journal
PLoS One
Volume 16, Issue 8, Pages e0255726
Publisher
Public Library of Science (PLoS)
Online
2021-08-13
DOI
10.1371/journal.pone.0255726
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Behavioral Tests in Neurotoxin-Induced Animal Models of Parkinson’s Disease
- (2020) E. Maruthi Prasad et al. Antioxidants
- Insulin Resistance and Oxidative Stress in the Brain: What’s New?
- (2019) Mateusz Maciejczyk et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- GLP-1’s role in neuroprotection: a systematic review
- (2019) Damla Erbil et al. BRAIN INJURY
- RoB 2: a revised tool for assessing risk of bias in randomised trials
- (2019) Jonathan A C Sterne et al. BMJ-British Medical Journal
- GIP has neuroprotective effects in Alzheimer and Parkinson’s disease models
- (2019) Zhen Qiang Zhang et al. PEPTIDES
- GIP analogues and the treatment of obesity-diabetes
- (2019) Clifford J. Bailey PEPTIDES
- Incretin hormones: Their role in health and disease
- (2018) Michael A. Nauck et al. DIABETES OBESITY & METABOLISM
- Facilitating healthcare decisions by assessing the certainty in the evidence from preclinical animal studies
- (2018) Carlijn R. Hooijmans et al. PLoS One
- D-Ala2-GIP-glu-PAL is neuroprotective in a chronic Parkinson's disease mouse model and increases BNDF expression while reducing neuroinflammation and lipid peroxidation
- (2017) Yanwei Li et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Insulin-Like Growth Factor-1 and Neuroinflammation
- (2017) Jose L. Labandeira-Garcia et al. Frontiers in Aging Neuroscience
- Levodopa in Parkinson’s Disease: Current Status and Future Developments
- (2017) Nicola Tambasco et al. Current Neuropharmacology
- Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's disease
- (2016) Henrik H Hansen et al. BRAIN RESEARCH
- The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of action
- (2016) Dilan Athauda et al. DRUG DISCOVERY TODAY
- Neuroendocrine abnormalities in Parkinson's disease
- (2016) Eduardo De Pablo-Fernández et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- The role of Insulin-Like Growth Factor 1 (IGF-1) in brain development, maturation and neuroplasticity
- (2016) Adam H. Dyer et al. NEUROSCIENCE
- Alpha-synuclein overexpression negatively regulates insulin receptor substrate 1 by activating mTORC1/S6K1 signaling
- (2015) Shanshan Gao et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Minimal clinically important difference on the Motor Examination part of MDS-UPDRS
- (2015) Krisztina Horváth et al. PARKINSONISM & RELATED DISORDERS
- Effects of Exendin-4 on bone marrow mesenchymal stem cell proliferation, migration and apoptosis in vitro
- (2015) Hao Zhou et al. Scientific Reports
- SYRCLE’s risk of bias tool for animal studies
- (2014) Carlijn R Hooijmans et al. BMC Medical Research Methodology
- Systematic Reviews and Meta-Analysis of Preclinical Studies: Why Perform Them and How to Appraise Them Critically
- (2014) Emily S Sena et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Glucagon-like peptide-1 receptors in the brain: controlling food intake and body weight
- (2014) Laurie L. Baggio et al. JOURNAL OF CLINICAL INVESTIGATION
- Diabetes is associated with postural and cognitive domains in Parkinson's disease. Results from a single-center study
- (2014) Martina Giuntini et al. PARKINSONISM & RELATED DISORDERS
- Metabolic inflammation exacerbates dopaminergic neuronal degeneration in response to acute MPTP challenge in type 2 diabetes mice
- (2013) Ling Wang et al. EXPERIMENTAL NEUROLOGY
- Pathogenesis of Parkinson's disease
- (2012) Etienne C. Hirsch et al. MOVEMENT DISORDERS
- Clinical features of Parkinson disease when onset of diabetes came first: A case-control study
- (2012) E. Cereda et al. NEUROLOGY
- GRADE guidelines: 7. Rating the quality of evidence—inconsistency
- (2011) Gordon H. Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- GRADE guidelines: 8. Rating the quality of evidence—indirectness
- (2011) Gordon H. Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- GRADE guidelines: 5. Rating the quality of evidence—publication bias
- (2011) Gordon H. Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- GRADE guidelines: 4. Rating the quality of evidence—study limitations (risk of bias)
- (2011) Gordon H. Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- GRADE guidelines 6. Rating the quality of evidence—imprecision
- (2011) Gordon H. Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Novel GLP-1 mimetics developed to treat type 2 diabetes promote progenitor cell proliferation in the brain
- (2011) A. Hamilton et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Neurotoxin-based models of Parkinson's disease
- (2011) J. Bové et al. NEUROSCIENCE
- Neurodegeneration in an animal model of Parkinson's disease is exacerbated by a high-fat diet
- (2010) Jill K. Morris et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Receptors for the incretin glucagon-like peptide-1 are expressed on neurons in the central nervous system
- (2009) Alison Hamilton et al. NEUROREPORT
- Quantitation of non-motor symptoms in Parkinson’s disease
- (2008) K. Ray Chaudhuri et al. EUROPEAN JOURNAL OF NEUROLOGY
- The Meaning of Translational Research and Why It Matters
- (2008) Steven H. Woolf JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Glucagon-like peptide 1 receptor stimulation by exendin-4 reverses key deficits in distinct rodent models of Parkinson's disease
- (2008) Alexander Harkavyi et al. Journal of Neuroinflammation
- The Unified Dyskinesia Rating Scale: Presentation and clinimetric profile
- (2008) Christopher G. Goetz et al. MOVEMENT DISORDERS
- Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results
- (2008) Christopher G. Goetz et al. MOVEMENT DISORDERS
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
- (2008) Gordon H Guyatt et al. BMJ-British Medical Journal
- Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of parkinson's disease
- (2007) Göran Bertilsson et al. JOURNAL OF NEUROSCIENCE RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started